- Report
- May 2025
- 375 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 303 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 486 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 184 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- March 2025
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- March 2025
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- December 2024
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- September 2024
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- March 2025
- 300 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- May 2025
- 62 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 191 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 183 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- January 2025
- 140 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- February 2025
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2025
- 175 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- April 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- March 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- March 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more